SYMPOSIA PROGRAMME

FRIDAY, 7 JUNE 2024

07.30h - 09.00h       Breakfast Satellite Symposium. KDIGO 2024 CKD Guideline - Regional Implementation Workshop

Meeting room: "BARCELONA A"

Agenda:

  • KDIGO Introduction on CKD Prevalence and Burden - David Wheeler
  • Successfull Collaborations between Nephrology and Primary Care - Xavier Cos (PCDE President)
  • Patient Cases Workshop
  • Regional Action-Plan Workshop
  • Closing remarks

Organized by KDIGO, Supported by an unrestricted educational grant by AstraZeneca

13.00 - 14.30h     Lunch Satellite Symposium. A Part of the STRIVE INITIATIVE. Diagnosis and Managing Obesity as a Chronic Disease: The Latest Evidence-Based Strategies and Targeted Therapeutic Advances to Reduce Weight and Optimize Patient-Centered Care.

Meeting room: "BARCELONA A"

Chairs:

Luca Bosetto (Associate Professor of Internal Medicine, University of Padova)
W. Timothy Garvey (Professor and University Professor of University of Alabama at Birmingham)

Agenda:

  • Pathophysiology
  • Treatment and diagnosis of people with obesity
  • Anti-obesity medications
  • Understanding obesity as a complex condition
  • Case studies
  • Conclusion
  • Questions and answers

Provided by Med Learning Group and supported by an educational grant from Lilly

17.00 - 18.30h     Afternoon Satellite Symposium. Connecting present and future in diabetes management: A novel CGM solution featuring the power of prediction

Meeting room: "BARCELONA A"

Chair: Rafael Simó (Spain)


Agenda:

  • Introduction
  • Be ready: What is needed to advance diabetes therapy in primary care - Naresh Kanumili (U.K.)
  • Be prepared: Taking diabetes management to a next level with the power of predictive analytics - Julia Mader (Austria)
  • Be in the know: Harness the potential of integrated technology to improve therapy outcomes - Oliver Schnell (Germany)
  • Discussion & Closing remarks

Sponsored by Roche Diabetes Care

SATURDAY, 8 JUNE 2024

08.15h - 09.15h       Breakfast Satellite Symposium. Constellations of care: navigating cardio, renal and metabolic conditions with SGLT2 inhibitors

Meeting room: "BARCELONA A"

Speakers: Dr. Ana Cebrián, Dr. Alberto Ortíz and Dr. Janaka Karalliedde

Agenda:

  • Welcome & Introduction
  • Charting the cardio, renal and metabolic landscape
  • Our patient as the North Star
  • A small step of the PCP, a big leap for the patient: practical considerations with SGLT2 inhibitors in cardio, renal and metabolic conditions
  • Summary and closing remarks

Sponsored by The Boehringer Ingelheim and Eli Lilly and Company Alliance